TVM Life Science Ventures VII has made the first investment in Montreal-based Kaneq Bioscience, a spin out company of Kaneq Pharma. Kaneq Bioscience was created for developing a protein tyrosine phosphatase1B (PTP-1B) inhibitor, designed ...
Tags: TVM Life Science, Pharma, Kaneq Pharma